South Korea's diagnostics industry sees wave of acquisitions of US CLIA-compliant labs, future uncertain due to possible regulatory changes

With the COVID-19 virus under control, Korean diagnostic testing companies have been acquiring laboratories that comply with the US CLIA (Clinical Laboratory Improvement Amendments) in recent years.